Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC12311 Eprobemide (LIS 630) Featured
Eprobemide is a non-competitive reversible inhibitor of monoamine oxidase A.
More description
DC11797 PBD-150 Featured
A potent glutaminyl cyclase (QC) inhibitor with Ki of 60 nM.
More description
DC11769 MPO-IN-28 Featured
A novel potent, irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.
More description
DC11160 Qstatin Featured
QStatin is a novel, potent, and selective Vibrio quorum sensing (QS) inhibitor, shows pan-QS inhibitor activity in diverse Vibrio species.
More description
DC22041 BTZO-1 Featured
BTZO-1 is a cardioprotective agent and Macrophage migration inhibitory factor (MIF) activator, binds to MIF with Kd of 68.6 nM, regulates ARE-mediated gene expression.
More description
DC21767 AG-1296 Featured
A potent and selective inhibitor of PDGFR with IC50 of about 0.4 uM both in vitro and in cells.
More description
DC20939 NCGC00379308 Featured
A potent, functionally selective TSH receptor (TSHR) positive allosteric modulator with EC50 of 11.6 uM (β-Arr 1 translocation).
More description
DC22493 ARA-290(Cibinetide) Featured
ARA-290 (Cibinetide) is a non-erythropoietic erythropoietin (EPO) derivative.
More description
DC21629 SC-236 Featured
SC-236 (SC58236) is a potent, selective, orally active inhibitor of COX-2 with IC50 of 10 nM.
More description
DC10165 AA26-9 Featured
AA26-9 is a potent and broad spectrum serine hydrolase inhibitor.
More description
DC20738 Livoletide Featured
A first-in-class analogue of unacylated ghrelin, and unacylated ghrelin receptor agonist.
More description
DC22832 Filastatin Featured
Filastatin is a long-lasting inhibitor of Candida albicans filamentation. Filastatin inhibits adhesion by multiple pathogenic Candida species with an IC50 of ~3 μM in the GFP-based adhesion assay. Filastatin inhibits fungal adhesion to polystyrene and human cells, the yeast-to-hyphal morphological transition, induction of the hyphal-specific HWP1 promoter. Filastatin has potent antifungal effect.
More description
DC20000 LR-90 Featured
LR-90 is an advanced glycation end product (AGE) inhibitor, inhibits inflammatory responses in human monocytes. LR-90 is also used in the research of diabetic animal model.
More description
DC22656 MM-401 Featured
A potent inhibitor of MLL1/WDR5 protein-protein interaction with IC50 of 0.9 nM.
More description
DC31982 S-2367(Velneperit) Featured
Velneperit, also known as S-2367, is potent and selective neuropeptide Y Y5-receptor antagonist under evaluating for treatment of obesity.
More description
DC8487 Gemcitabine elaidate Featured
Gemcitabine elaidate is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity.
More description
DC8829 Betahistine EP Impurity C(NSC19005) Featured
N-Methyl-N,N-bis(2-pyridylethyl)amine is used as a reagent in the preparation of copper pyridylmethylethylenediamine dicyanamido polymeric complexes.
More description
DC26117 ZT-12-037-01 Featured
ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor with IC50 of 20.04 nM measured as percentage of NRAS phosphorylation; shows similar IC50 of 23.96 and 27.94 nM for STK19WTWT STK19D89N respectively; displays extremely high kinase selectivity using KINOMEscan against a panel of 468 diverse kinases using an in vitro ATP-site competition binding assay at 1 uM; efficiently inhibits phosphorylation of NRAS in a dose- and time-dependent manner, inhibits NRAS activity in a dose-dependent manner but does not affect the levels of H3K9 methylation; effectively inhibits NRAS signaling, including the MEK-ERK and PI3K pathways in SK-MEL-2 and WM2032 cells (with NRASQ61R), but the inhibition was much less effective in A375 or UACC62 cells (with NRASWT), effectively inhibits cell growth and induces apoptosis of SK-MEL-2 and WM2032 melanoma cells.
More description
DC20622 Asciminib Featured
Asciminib (ABL-001) is a potent and selective allosteric ABL1 inhibitor with IC50 of 0.25 nM in BCR–ABL1-transformed BaF3 cells.
More description
DC12307 RCGD423 Featured
RCGD423 is a gp130 modulator, which prevents articular cartilage degeneration and promotes repair.
More description
DC22833 KKL-35 Featured
A small molecule inhibitor of trans-translation that has broad-spectrum antibiotic activity.
More description
DC24074 CX-546 Featured
CX546 is an AMPA receptor potentiator and GluR activator, binds specifically to the agonist bound non-desensitized receptor.
More description
DC12564 TH-257 Featured
TH-257 (TH257) is a potent, selective, allosteric inhibitor of LIMK1 and LIMK2 with IC50 of 84 nM for LIMK1 and 39 nM for LIMK2 in a RapidFire MS assay.
More description
DC20731 AZD-7325 Featured
AZD-7325 is a potent, α2/3 functionally selective, partial GABAA receptor modulator with pKi of 9.51.
More description
DC7803 CCT007093 Featured
CCT007093 is a potent PPM1D (WIP1) inhibitor with IC50 of 8.4 μM.
More description
DC24083 4-IBP Featured
A highly potent sigma receptor agonist with Ki of 1.7 nM and 25.2 nM for σ1 and σ2, respectively.
More description
DC12285 CID 1375606 Featured
CID 1375606 is a surrogate agonist of orphan G protein-coupled receptor GPR27.
More description
DC12158 AKOS B018304 Featured
AKOS B018304 is an arylalkylidene derivative, with polar substitution at para-position.
More description
DC26024 GNE-8324 Featured
GNE-8324 is a potent and selective NMDA receptor PAM.
More description
DC21807 VU 0465350 Featured
VU 0465350 is a potent, specific BMP receptor activin receptor-like kinase 3 (ALK3) antaognist with Ki of 92.3 nM; shows no activity for ALK2/4/5, also shows affinity for TGFBR2, VEGFR2 and AMPK; blocks SMAD phosphorylation in vitro and in vivo, and enhances liver regeneration after partial hepatectomy.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X